Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.50 |
| ▸ | P2RX7 | Q99572 | 8/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.42 |
| ▸ | GPR119 | Q8TDV5 | 4/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CKS1B | P61024 | 2/20 | 0.39 |
| ▸ | SKP1 | P63208 | 2/20 | 0.39 |
| ▸ | SKP2 | Q13309 | 2/20 | 0.39 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28734981 | 0.83 | P2RX7 (0.53) | PDK2P2RX7HDAC4HDAC1HDAC6 | |
| SCHEMBL27240288 | 0.80 | NR1H2 (0.45) | PDK2NR1H2GPR119POLBCKS1B | |
| SCHEMBL28886725 | 0.80 | PDK2 (0.47) | PDK2P2RX7NR1H2GPR119 | |
| SCHEMBL30191401 | 0.80 | P2RX7 (0.45) | PDK2P2RX7HDAC4HDAC1HDAC6 | |
| SCHEMBL15519766 | 0.79 | CFTR (0.48) | PDK2P2RX7HDAC4HDAC1HDAC6 | |
| SCHEMBL25275872 | 0.78 | CFTR (0.47) | PDK2P2RX7HDAC4HDAC1HDAC6 | |
| SCHEMBL30457735 | 0.78 | CFTR (0.47) | PDK2P2RX7HDAC4HDAC1HDAC6 | |
| SCHEMBL10095054 | 0.77 | PDK2 (0.48) | PDK2P2RX7NR1H2GPR119POLB | |
| SCHEMBL16836088 | 0.76 | MTOR (0.47) | PDK2P2RX7HDAC4HDAC1HDAC6 | |
| SCHEMBL17790245 | 0.76 | P2RX7 (0.48) | PDK2P2RX7NR1H2GPR119POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114456173-B | Condensed ring group substituted cyclohexanediimide derivative, preparation method and medical application thereof | 江苏恒瑞医药股份有限公司 | 2023-09-19 | — | — | CN | disclosed |
| CN-114456173-A | Fused ring group substituted cycloheximide derivatives, preparation method thereof and application thereof in medicines | 江苏恒瑞医药股份有限公司 | 2022-05-10 | — | — | CN | disclosed |